Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

How to reflect brand values and appeal to your target audience - The secret to designing a logo that leaves a lasting impression ...